LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 171

Search options

  1. Book ; Online ; E-Book: Complications of pain-relieving procedures

    Erdine, Serdar / Staats, Peter S.

    an illustrated guide

    2022  

    Author's details edited by Serdar Erdine, Peter S. Staats
    Language English
    Size 1 Online-Ressource (xxviii, 597 Seiten), Illustrationen
    Publisher Wiley Blackwell
    Publishing place Chichester
    Publishing country Great Britain
    Document type Book ; Online ; E-Book
    Remark Zugriff für angemeldete ZB MED-Nutzerinnen und -Nutzer
    HBZ-ID HT021448907
    ISBN 9781119757283 ; 9781119757290 ; 9781119757306 ; 9781119757276 ; 1119757282 ; 1119757290 ; 1119757304 ; 1119757274
    Database ZB MED Catalogue: Medicine, Health, Nutrition, Environment, Agriculture

    Kategorien

  2. Book: Atlas of pain medicine procedures

    Diwan, Sudhir / Staats, Peter S.

    2015  

    Title variant Pain medicine procedures
    Author's details Sudhir Diwan ; Peter S. Staats
    Keywords Pain Management / methods ; Pain / drug therapy ; Analgesics / therapeutic use ; Analgesia / methods
    Language English
    Size XXIV, 728 S. : zahlr. Ill.
    Publisher McGraw Hill Med
    Publishing place New York u.a.
    Publishing country United States
    Document type Book
    Note Includes bibliographical references and index
    HBZ-ID HT018581513
    ISBN 978-0-07-173876-7 ; 0-07-173876-2
    Database Catalogue ZB MED Medicine, Health

    More links

    Kategorien

  3. Article ; Online: Device profile of the Evoke physiologic closed-loop spinal cord stimulation system for the treatment of chronic intractable pain: overview of its safety and efficacy.

    Poree, Lawrence / Foster, Allison / Staats, Peter S

    Expert review of medical devices

    2023  Volume 20, Issue 11, Page(s) 885–898

    Abstract: Introduction: The Evoke® spinal cord stimulation (SCS) device enables the closed-loop feedback of dynamically measured evoked compound action potentials (ECAPs) to adjust stimulation amplitude for every stimulation pulse to maintain the stimulation ... ...

    Abstract Introduction: The Evoke® spinal cord stimulation (SCS) device enables the closed-loop feedback of dynamically measured evoked compound action potentials (ECAPs) to adjust stimulation amplitude for every stimulation pulse to maintain the stimulation output level near a targeted ECAP amplitude. No other commercially available SCS device presently uses physiologic feedback from the spinal cord to adjust stimulation. Clinicians should be familiar with the differences in devices and with the latest technologies to provide optimized patient care.
    Areas covered: In this device profile, the Evoke system is described and the system capabilities are differentiated from other available SCS devices. A systematic review was conducted based on best practice guidance to identify all available evidence on the safety and efficacy of the Evoke SCS system.
    Expert opinion: The Evoke SCS system offers unique capabilities as a means to optimize therapy delivery tailored to each individual patient. Data through 24-months follow-up show statistically significant, clinically meaningful, ample, consistent, and strong evidence of the safety and efficacy of the Evoke system for the treatment of chronic intractable pain.
    Language English
    Publishing date 2023-09-13
    Publishing country England
    Document type Journal Article
    ZDB-ID 2250857-0
    ISSN 1745-2422 ; 1743-4440
    ISSN (online) 1745-2422
    ISSN 1743-4440
    DOI 10.1080/17434440.2023.2255520
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: fMRI in vagus nerve stimulation for migraine: a biomarker-based approach to pain research.

    Doshi, Tina L / Staats, Peter S

    Regional anesthesia and pain medicine

    2021  Volume 46, Issue 6, Page(s) 467–468

    Language English
    Publishing date 2021-02-15
    Publishing country England
    Document type Editorial
    ZDB-ID 1425299-5
    ISSN 1532-8651 ; 1098-7339 ; 0146-521X
    ISSN (online) 1532-8651
    ISSN 1098-7339 ; 0146-521X
    DOI 10.1136/rapm-2020-102404
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Book: Interventional pain management

    Staats, Peter S.

    (Anesthesiology clinics of North America ; 21,4)

    2003  

    Author's details Peter S. Staats, guest ed
    Series title Anesthesiology clinics of North America ; 21,4
    Collection
    Language English
    Size XIV S., S. 699 - 857 : Ill.
    Publisher Saunders
    Publishing place Philadelphia u.a.
    Publishing country United States
    Document type Book
    HBZ-ID HT013901100
    Database Catalogue ZB MED Medicine, Health

    More links

    Kategorien

  6. Article ; Online: Vagus nerve stimulation in rheumatoid arthritis.

    Staats, Peter S / Poree, Lawrence

    The Lancet. Rheumatology

    2020  Volume 3, Issue 1, Page(s) e14

    Language English
    Publishing date 2020-08-20
    Publishing country England
    Document type Letter
    ISSN 2665-9913
    ISSN (online) 2665-9913
    DOI 10.1016/S2665-9913(20)30360-X
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Effect of Provider Specialty on Medical Resource Utilization and Costs in Chronic Spinal-Pain Management.

    Staats, Peter S / Vallejo, Ricardo / Gasquet, Nicolas C / Ricker, Christine N

    Pain physician

    2023  Volume 26, Issue 2, Page(s) 207–217

    Abstract: Background: Poorly managed chronic spinal pain encumbers medical resources and drives healthcare costs, suggesting a target for improvement.: Objectives: To determine how specialist-care pathways influence healthcare costs in the first year after a ... ...

    Abstract Background: Poorly managed chronic spinal pain encumbers medical resources and drives healthcare costs, suggesting a target for improvement.
    Objectives: To determine how specialist-care pathways influence healthcare costs in the first year after a referral for chronic spine pain.
    Study design: This was a retrospective cohort analysis of administrative claims from a large commercial health insurance provider, analyzing a 6-month baseline, a variable "pre-referral period," and a one-year period of specialist care.
    Setting: US patients covered by private commercial insurers.
    Methods: Adult patients diagnosed with chronic, spine-related pain between July 2016 and February 2018 and under the active care of a specialist were eligible. Patients with neurological deficits or cancer-related pain were excluded. Patients were categorized based on sequence-dependent exposure to a pain specialist, a surgeon, or both specialties. Key measures were pain-related and all-cause medical resource use and costs and opioid prescription fills.
    Results: Of 306,080 eligible patients (mean age 61.6; 61.5% women), 13% saw a pain specialist, 71% a surgeon, 7% a pain specialist then a surgeon, and 9% a surgeon then a pain specialist. Referral to a pain specialist alone was associated with lower resource use and per-patient adjusted cost savings of $3,311 (pain-related) and $6,447 (all-cause) compared to patients referred to a surgeon alone. The pain specialist pathway was associated with increased indicators of prescription opioid use.
    Limitations: Cohort design constraints temper the results' generalizability, given the need to simultaneously examine specialty pathway and medical resource incurred over the same time period.
    Conclusions: We observed meaningful savings in cost and resource use when chronic spine-pain patients were managed by pain specialists. Pain-management referrals should be an element of a thoughtfully designed care pathway.
    MeSH term(s) Adult ; Humans ; Female ; Middle Aged ; Male ; Analgesics, Opioid/therapeutic use ; Retrospective Studies ; Pain Management ; Health Care Costs ; Pain
    Chemical Substances Analgesics, Opioid
    Language English
    Publishing date 2023-03-29
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2146393-1
    ISSN 2150-1149 ; 1533-3159
    ISSN (online) 2150-1149
    ISSN 1533-3159
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Trial Design and Endpoint Evaluation in Clinical Studies Addressing Chronic Back Pain.

    Staats, Peter S

    Spine

    2017  Volume 42 Suppl 14, Page(s) S93–S97

    Abstract: Study design: A review of the literature evaluating clinical trials of chronic back pain.: Objective: To assist physicians in assessing the quality of clinical trial data to make the most informed treatment decisions.: Summary of background data: ... ...

    Abstract Study design: A review of the literature evaluating clinical trials of chronic back pain.
    Objective: To assist physicians in assessing the quality of clinical trial data to make the most informed treatment decisions.
    Summary of background data: Chronic pain is a tremendous public health issue, affecting close to 100 million adults in the United States, and costs the American people billions of dollars. One traditional treatment approach, the long-term use of opiate medications, has recently come under intense scrutiny for problems with complications, diversion, abuse, addiction, and lack of efficacy. In addition, the Centers for Disease Control and Prevention has recognized that overprescribing opiates has enabled an overdose crisis, and written guidelines that are intended to limit their use. It is for this reason that physicians must have a comprehensive understanding of the range of drug-free alternative therapies available and have the tools needed to rigorously evaluate the chronic pain literature so they can make appropriate treatment decisions.
    Methods: An evaluation of how clinical trials are designed and ranked, outcome measures, and costs for a variety of therapies is necessary to determine which treatment option is the most efficacious for an individual patient.
    Results: Clinical trial data demonstrate that spinal cord stimulation (SCS) is a safe and effective treatment option for many types of chronic pain, including back pain. The last 10 years has brought tremendous advances in the field of neuromodulation. Today, several treatment modalities exist for SCS requiring the physician to be able to critically evaluate and interpret the literature and determine which modality has the strongest evidence. When evaluating clinical trial data of patients with chronic back pain, emphasis must be placed on well designed, randomized controlled trials with long-term follow-up producing level I evidence. These data are obtained in a rigorous manner and are likely to have less bias when compared with lower level studies.
    Conclusion: The level I studies performed to date have provided evidence that treatment with SCS results in sustainable pain reduction and improvements in scores measuring quality of life and patient functioning in those patients with chronic intractable back pain.
    Level of evidence: 5.
    MeSH term(s) Back Pain/diagnosis ; Back Pain/therapy ; Chronic Pain/diagnosis ; Chronic Pain/therapy ; Clinical Trials as Topic/methods ; Clinical Trials as Topic/standards ; Complementary Therapies/methods ; Complementary Therapies/standards ; Endpoint Determination/methods ; Endpoint Determination/standards ; Humans ; Pain Management/methods ; Pain Management/standards ; Quality of Life ; Spinal Cord Stimulation/methods ; Spinal Cord Stimulation/standards ; Treatment Outcome
    Language English
    Publishing date 2017-03-30
    Publishing country United States
    Document type Journal Article
    ZDB-ID 752024-4
    ISSN 1528-1159 ; 0362-2436
    ISSN (online) 1528-1159
    ISSN 0362-2436
    DOI 10.1097/BRS.0000000000002201
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Response to Letter to the Editor Regarding: "The Use of Non-Invasive Vagus Nerve Stimulation to Treat Respiratory Symptoms Associated With COVID-19: A Theoretical Hypothesis and Early Clinical Experience".

    Staats, Peter S / Levy, Robert

    Neuromodulation : journal of the International Neuromodulation Society

    2020  Volume 23, Issue 7, Page(s) 1044–1045

    MeSH term(s) COVID-19 ; Humans ; Pandemics ; SARS-CoV-2 ; Vagus Nerve ; Vagus Nerve Stimulation
    Keywords covid19
    Language English
    Publishing date 2020-09-21
    Publishing country United States
    Document type Letter ; Comment
    ZDB-ID 1500372-3
    ISSN 1525-1403 ; 1094-7159
    ISSN (online) 1525-1403
    ISSN 1094-7159
    DOI 10.1111/ner.13271
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Percutaneous image-guided lumbar decompression and interspinous spacers for the treatment of lumbar spinal stenosis: A 2-year Medicare Claims Benchmark Study.

    Staats, Peter S / Hagedorn, Jonathan M / Reece, David E / Strand, Natalie H / Poree, Lawrence

    Pain practice : the official journal of World Institute of Pain

    2023  Volume 23, Issue 7, Page(s) 776–784

    Abstract: Objective: This prospective longitudinal study compares outcomes between Medicare beneficiaries receiving percutaneous image-guided lumbar decompression (PILD) using the mild® procedure and a control group of patients receiving interspinous spacers for ... ...

    Abstract Objective: This prospective longitudinal study compares outcomes between Medicare beneficiaries receiving percutaneous image-guided lumbar decompression (PILD) using the mild® procedure and a control group of patients receiving interspinous spacers for the treatment of lumbar spinal stenosis (LSS) with neurogenic claudication (NC).
    Methods: Patients diagnosed with LSS with NC and treated with either the mild procedure or a spacer were identified in the Medicare claims database. The incidence of harms, the rate of subsequent interventions, and the overall combined rate of harms and subsequent interventions during 2-year follow-up after the index procedure were compared between the two groups and assessed for statistical significance with p = 0.05.
    Results: The study included 2229 patients in the mild group and 3401 patients who were implanted with interspinous spacers. The rate of harms for those treated with the mild procedure was less than half that of patients implanted with a spacer (5.6% vs. 12.1%, respectively; p < 0.0001) during 2-year follow-up. The rate of subsequent interventions was not significantly different between the two groups (24.9% and 26.1% for the mild and spacer groups, respectively; p = 0.7679). The total rate of harms and subsequent interventions for mild was found to be noninferior to spacers (p < 0.0001).
    Conclusions: This comprehensive study of real-world Medicare claims data demonstrated a significantly lower rate of harms for the mild procedure compared to interspinous spacers for patients diagnosed with LSS with NC, and a similar rate of subsequent interventions during 2-year follow-up.
    MeSH term(s) Humans ; Aged ; United States/epidemiology ; Spinal Stenosis/surgery ; Prospective Studies ; Benchmarking ; Longitudinal Studies ; Decompression, Surgical/methods ; Medicare ; Back Pain/etiology ; Chronic Pain/etiology ; Lumbar Vertebrae/surgery ; Treatment Outcome
    Language English
    Publishing date 2023-05-30
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2151272-3
    ISSN 1533-2500 ; 1530-7085
    ISSN (online) 1533-2500
    ISSN 1530-7085
    DOI 10.1111/papr.13256
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top